Boothbay Fund Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-311,040
| Closed | -$41.8K | – | 1699 |
|
|
2024
Q4 | $41.8K | Hold |
311,040
| – | – | ﹤0.01% | 1210 |
|
|
2024
Q3 | $36.4K | Hold |
311,040
| – | – | ﹤0.01% | 1333 |
|
|
2024
Q2 | $37.5K | Hold |
311,040
| – | – | ﹤0.01% | 1265 |
|
|
2024
Q1 | $44.5K | Hold |
311,040
| – | – | ﹤0.01% | 1304 |
|
|
2023
Q4 | $46.6K | Hold |
311,040
| – | – | ﹤0.01% | 1364 |
|
|
2023
Q3 | $71.5K | Hold |
311,040
| – | – | ﹤0.01% | 1402 |
|
|
2023
Q2 | $59.5K | Hold |
311,040
| – | – | ﹤0.01% | 1442 |
|
|
2023
Q1 | $51.3K | Buy |
+311,040
| New | +$51.3K | ﹤0.01% | 1765 |
|